Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Heliyon|March 5, 2024
Correlation of mitochondrial respiration in platelets, peripheral blood mononuclear cells and muscle fibersEmil Westerlund, Sigurður E Marelsson, Michael Karlsson, et al.
BMJ Open|December 30, 2025
STEM-PD trial protocol: a multi-centre, single-arm, first-in-human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson's diseaseGesine Paul, Hjalmar Bjartmarz, Anders Björklund, et al.
Stem Cells (Dayton, Ohio)|March 25, 2006
Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formationAnke Brederlau, Ana Sofia Correia, Sergey V Anisimov, et al.
The Journal of Clinical Investigation|February 18, 2015
Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson's disease patientsGesine Paul, Olof Zachrisson, Andrea Varrone, et al.
Brain Communications|September 11, 2025
Mapping the distribution of neurotransmitters to resting-state functional connectivity in Parkinson's diseaseWeihua Li, Nicholas P Lao-Kaim, Runtian Li, et al.
Life Science Alliance|September 22, 2020
Human G-MDSCs are neutrophils at distinct maturation stages promoting tumor growth in breast cancerMeliha Mehmeti-Ajradini, Caroline Bergenfelz, Anna-Maria Larsson, et al.
Cell Reports|July 3, 2026
STING-dependent peripheral inflammaging drives neurodegeneration via extracellular vesiclesMaria Öberg, Caitlyn Myers, Najmeh Saffarzadeh, et al.
Brain : a Journal of Neurology|May 6, 2026
Neuroinflammation and neurodegeneration trigger a specific splice form of ribosomal protein S24Srivathsa S Magadi, Maria Jonson, Pablo B Lucena, et al.
Cell Stem Cell|October 6, 2023
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PDAgnete Kirkeby, Jenny Nelander, Deirdre B Hoban, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 22, 2023
Intraputamenal Cerebral Dopamine Neurotrophic Factor in Parkinson's Disease: A Randomized, Double-Blind, Multicenter Phase 1 TrialHenri J Huttunen, Sigrid Booms, Magnus Sjögren, et al.
Pageof 7